Pancreatic Cancer
Pancreatic cancer, specifically pancreatic ductal adenocarcinoma, is a type of cancer that begins in the cells of the pancreas. It is often diagnosed at an advanced stage and can be challenging to treat.
Pancreatic Cancer: TCR-Modified T-Cell Therapy
We are studying a new therapy using modified T-cells for adults with advanced pancreatic cancer that has specific genetic mutations. The trial aims to assess safety and how well this treatment may work.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years or older?
- Do you have newly diagnosed metastatic pancreatic cancer (PDAC) or locally advanced PDAC?
- Are you currently pregnant or breastfeeding?
- Do you have any other major health issues like active infections or severe heart problems?
- Are you currently taking any systemic steroids?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Anoc-001
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Region Hovedstaden
Oncology
Rødovre, Denmark
Universitaetsklinikum Carl Gustav Carus Dresden an der Technischen Universitaet Dresden AöR
Oncology
Dresden, Germany
Universitaetsklinikum Heidelberg AöR
Medical Oncology
Heidelberg, Germany
Sponsor: Anocca AB
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.